SYRS vs MSFT: Which Stock is Better?
Side-by-side comparison of Syros Pharmaceuticals Inc and Microsoft Corp in 2026
SYRS
Syros Pharmaceuticals Inc
$0.00
MSFT
Microsoft Corp
$422.50
Key Metrics Comparison
| Metric | SYRS | MSFT | Winner |
|---|---|---|---|
| Market Cap | $0.01M | N/A | SYRS |
| P/E Ratio | N/A | 26.31 | MSFT |
| EPS (TTM) | $N/A | $16.07 | MSFT |
| Revenue Growth | -0.0% | 0.2% | MSFT |
| Gross Margin | -22863.0% | 68.6% | MSFT |
Analyze SYRS
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SYRS or MSFT a better investment?
Comparing SYRS and MSFT: Syros Pharmaceuticals Inc has a market cap of $0.01M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SYRS and MSFT?
SYRS (Syros Pharmaceuticals Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SYRS or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: SYRS or MSFT?
MSFT has higher revenue growth at 0.2% vs -0.0% for SYRS.
Which company is more profitable: SYRS or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to -22863.0% for SYRS.
Which is the larger company: SYRS or MSFT?
Syros Pharmaceuticals Inc (SYRS) is larger with a market cap of $0.01M compared to N/A for MSFT.
Should I buy SYRS or MSFT in 2026?
Both SYRS and MSFT have investment merit. SYRS trades at $0.00 while MSFT trades at $422.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SYRS and MSFT stock?
Key differences: Market Cap ($0.01M vs N/A), P/E Ratio (N/A vs 26.3x), Revenue Growth (-0.0% vs 0.2%), Gross Margin (-22863.0% vs 68.6%).